Literature DB >> 17960113

Glucocorticoids induce retinal toxicity through mechanisms mainly associated with paraptosis.

Fatemeh Valamanesh1, Alicia Torriglia, Michéle Savoldelli, Christelle Gandolphe, Jean-Claude Jeanny, David BenEzra, Francine Behar-Cohen.   

Abstract

PURPOSE: Corticosteroids have recorded beneficial clinical effects and are widely used in medicine. In ophthalmology, besides their treatment benefits, side effects, including ocular toxicity have been observed especially when intraocular delivery is used. The mechanism of these toxic events remains, however, poorly understood. In our present study, we investigated the mechanisms and potential pathways of corticosteroid-induced retinal cell death.
METHODS: Rats were sacrificed 24 h and 8 days after an intravitreous injection of 1 microl (40 microg) of Kenacort Retard. The eyes were processed for ultra structure analysis and detection of activated caspase-3, cytochrome-C, apoptosis-inducing factor (AIF), LEI-L-Dnase II, terminal transferase dUTP nick end labeling (TUNEL), and microtubule-associated protein 1-light chain 3 (MAP-LC3). In vitro, rat retinal pigment epithelial cells (RPE), retinal Müller glial cells (RMG) and human ARPE-19 cells were treated with triamcinolone acetonide (TA) or other glucocorticoids. Cell viability was quantified by 3-(4,5-dimethylthiazol-2-yl)-2,5 phenyltetrazolium bromide test (MTT) assay and cell counts. Nuclei staining, TUNEL assay, annexin-V binding, activated caspase-3 and lactate dehydrogenase (LDH) production characterized cell death. Localization of cytochrome-C, AIF, LEI-and L-Dnase II, and staining with MAP-LC3 or monodansylcadaverine were also carried out. Finally, ARPE-19 cells transfected with AIP-1/Alix were exposed to TA.
RESULTS: In vitro incubation of retinal cell in the presence of corticosteroids induced a specific and dose-dependent reduction of cell viability. These toxic events were not associated with the anti-inflammatory activity of these compounds but depended on the hydro solubility of their formulation. Before cell death, extensive cytoplasmic vacuolization was observed in the retinal pigment epithelial (RPE) cells in vivo and in vitro. The cells however, did not show known caspase-dependent or caspase-independent apoptotic reactions. These intracellular vacuoles were negative for MAP-LC3 but some stained positive for monodansylcadaverine. Furthermore, over expression of AIP-1/Alix inhibited RPE cell death.
CONCLUSIONS: These observations suggest that corticosteroid-induced retinal cell death may be carried out mainly through a paraptosis pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17960113

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


  16 in total

1.  Nonsteroid anti-inflammatory therapy suppresses the development of proliferative vitreoretinopathy more effectively than a steroid one.

Authors:  Marina V Tikhonovich; Aleksei K Erdiakov; Svetlana A Gavrilova
Journal:  Int Ophthalmol       Date:  2017-06-21       Impact factor: 2.031

2.  Compared antioxidant activity among corticosteroids on cultured retinal pigment epithelial cells.

Authors:  Nuzzi Raffaele; Alessandro Marchese; Dario Ghigo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-10-14       Impact factor: 3.117

3.  Otx2 gene deletion in adult mouse retina induces rapid RPE dystrophy and slow photoreceptor degeneration.

Authors:  Francis Béby; Michael Housset; Nicolas Fossat; Coralie Le Greneur; Frédéric Flamant; Pierre Godement; Thomas Lamonerie
Journal:  PLoS One       Date:  2010-07-21       Impact factor: 3.240

4.  Glucocorticoid-induced autophagy in osteocytes.

Authors:  Xuechun Xia; Rekha Kar; Jelica Gluhak-Heinrich; Wei Yao; Nancy E Lane; Lynda F Bonewald; Sondip K Biswas; Woo-Kuen Lo; Jean X Jiang
Journal:  J Bone Miner Res       Date:  2010-11       Impact factor: 6.741

5.  Effects of triamcinolone acetonide on vessels of the posterior segment of the eye.

Authors:  Fatemeh Valamanesh; Marianne Berdugo; Florian Sennlaub; Michèle Savoldelli; Cyndie Goumeaux; Marianne Houssier; Jean-Claude Jeanny; Alicia Torriglia; Francine Behar-Cohen
Journal:  Mol Vis       Date:  2009-12-08       Impact factor: 2.367

6.  Resolution of vitreomacular traction following intravitreal triamcinolone acetonide injection in an eye with branch retinal vein occlusion.

Authors:  Göktuğ Seymenoğlu; Ozcan Kayıkçıoğlu; Bilge Öztürk Sahin
Journal:  Clin Ophthalmol       Date:  2012-08-02

7.  Triamcinolone acetonide and anecortave acetate do not stimulate uveal melanoma cell growth.

Authors:  Mariam El Filali; Irene Homminga; Willem Maat; Pieter A van der Velden; Martine J Jager
Journal:  Mol Vis       Date:  2008-09-24       Impact factor: 2.367

8.  Effects of sub-Tenon's capsule triamcinolone acetonide injection combined with microaneurysm photocoagulation on diabetic macular edema.

Authors:  Toshiyuki Oshitari; Sakiko Nonomura; Miyuki Arai; Yoko Takatsuna; Eiju Sato; Takayuki Baba; Shuichi Yamamoto
Journal:  Int Med Case Rep J       Date:  2015-12-07

9.  Stronger proteasomal inhibition and higher CHOP induction are responsible for more effective induction of paraptosis by dimethoxycurcumin than curcumin.

Authors:  M J Yoon; Y J Kang; J A Lee; I Y Kim; M A Kim; Y S Lee; J H Park; B Y Lee; I A Kim; H S Kim; S-A Kim; A-R Yoon; C-O Yun; E-Y Kim; K Lee; K S Choi
Journal:  Cell Death Dis       Date:  2014-03-13       Impact factor: 8.469

10.  Effects of triamcinolone acetonide on human trabecular meshwork cells in vitro.

Authors:  Ashish Sharma; A Jayaprakash Patil; Navin Gupta; M F Estrago-Franco; Saffar Mansoor; Vincent Raymond; M Cristina Kenney; Baruch D Kuppermann
Journal:  Indian J Ophthalmol       Date:  2014-04       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.